Filing Details

Accession Number:
0001213900-22-027983
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-18 17:21:07
Reporting Period:
2022-05-17
Accepted Time:
2022-05-18 17:21:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410098 Cormedix Inc. CRMD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1672645 Myron Kaplan C/O Cormedix Inc. 300 Connell
Drive, 300 Connell Drive, Suite 4200
Berkeley Heights NJ 07922
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-17 5,000 $3.78 160,034 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect Spouse
Common Stock 10,000 Indirect Spouse as Guardian for Grandchildren
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy Common Stock) $4.03 2032-02-22 20,000 20,000 Direct
Common Stock Stock Option (Right to Buy Common Stock) $8.32 2031-01-11 30,000 30,000 Direct
Common Stock Stock Option (Right to Buy Common Stock) $5.63 2030-02-25 15,000 15,000 Direct
Common Stock Stock Option (Right to Buy Common Stock) $8.30 2029-01-10 15,000 15,000 Direct
Common Stock Stock Option (Right to(Right to Buy Common Stock) $2.85 2028-02-16 8,000 8,000 Direct
Common Stock Stock Option (Right to Buy Common Stock) $11.20 2027-02-21 8,000 8,000 Direct
Common Stock Stock Option (Right to Buy Common Stock) $21.40 2026-04-28 10,000 1,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2032-02-22 20,000 20,000 Direct
2031-01-11 30,000 30,000 Direct
2030-02-25 15,000 15,000 Direct
2029-01-10 15,000 15,000 Direct
2028-02-16 8,000 8,000 Direct
2027-02-21 8,000 8,000 Direct
2026-04-28 10,000 1,000 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.77 to $3.79,inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and ExchangeCommission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote tothis Form 4.
  2. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is thebeneficial owner of the securities for purposes of Section 16 or for any other purpose.
  3. These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continuedservice on the board.
  4. These options were granted on 1/11/2021. These options are fully vested.
  5. These options were granted on 2/25/2020. These options are fully vested.
  6. These options were granted on 1/10/2019. These options are fully vested.
  7. These options were granted on 2/16/2018. These options are fully vested.
  8. These options were granted on 2/21/2017. These options are fully vested.
  9. These options were granted on 4/28/2016. These options are fully vested.